Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.
about
Lymphangioleiomyomatosis: differential diagnosis and optimal managementSustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestationsTherapeutic Strategies for Treatment of Pulmonary Lymphangioleiomyomatosis (LAM)The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.Lymphangioleiomyomatosis: New Treatment Perspectives.Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases.Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.2016 - a second step.Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.Oral Doxycycline Reduces the Total Number of Intraocular Bevacizumab Injections Needed to Control Neovascular Age-related Macular Degeneration.Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).Doxycycline Attenuates Atrial Remodeling by Interfering with MicroRNA-21 and Downstream Phosphatase and Tensin Homolog (PTEN)/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway
P2860
Q27022412-F16F86F7-0255-47A1-8BA6-B5A12DBD3E59Q35044713-912168B0-B94A-4998-9B28-FA11283FD569Q35971499-5F4CA6D0-E278-4A5D-BA42-B2D8E20DD7A5Q36462100-B99B1C49-A723-491E-BD88-A04CFE1CD5A1Q38372196-1A856E10-CF0F-4B44-8925-BB4AF4656434Q38484497-04226F00-E977-41FD-B241-31956D865CCCQ38786719-EBE53C2D-0067-414D-9BBA-A39AF4127D9AQ38895095-6DAD6F88-CC6A-4575-97E8-F41A716931A0Q42937721-7568E12A-3C93-4D0D-96FA-905E015C51E2Q48355779-9C9F3BE9-65E3-4B5D-B101-04111DB02372Q48524275-3161C429-6628-4CA7-9763-AC62080E5545Q51698891-C8C20151-0D8A-4CF0-92B8-F8D2122F5FEEQ58788423-2FCC7143-4B9C-45F2-846E-5F72974AC42E
P2860
Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Doxycycline use in patients wi ...... d pulmonary function response.
@ast
Doxycycline use in patients wi ...... d pulmonary function response.
@en
type
label
Doxycycline use in patients wi ...... d pulmonary function response.
@ast
Doxycycline use in patients wi ...... d pulmonary function response.
@en
prefLabel
Doxycycline use in patients wi ...... d pulmonary function response.
@ast
Doxycycline use in patients wi ...... d pulmonary function response.
@en
P2093
P2860
P1476
Doxycycline use in patients wi ...... d pulmonary function response.
@en
P2093
Bruno Guedes Baldi
Carlos Roberto Ribeiro Carvalho
Ronaldo Adib Kairalla
Suzana Pinheiro Pimenta
P2860
P356
10.1590/S1806-37132013000100002
P577
2013-01-01T00:00:00Z